These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1782992)

  • 21. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice.
    Joshi VV; Balsara JJ; Jadhav JH; Chandorkar AG
    Eur J Pharmacol; 1981 Feb; 69(4):499-502. PubMed ID: 6113966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel antagonist isradipine attenuates cocaine-induced motor activity in rats: correlation with brain monoamine levels.
    Mills K; Arsah TA; Ali SF; Shockley DC
    Ann N Y Acad Sci; 1998 May; 844():201-7. PubMed ID: 9668678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration.
    Gäddnäs H; Pietilä K; Alila-Johansson A; Ahtee L
    Brain Res; 2002 Dec; 957(1):76-83. PubMed ID: 12443982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.
    Kelly PH; Miller RJ
    Br J Pharmacol; 1975 May; 54(1):115-21. PubMed ID: 1139072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional effects of ceruletide, a cholecystokinin-8 analog, on the striatal monoaminergic systems in food-deprived mice.
    Yamada T; Kimura H
    Brain Res; 1991 Feb; 540(1-2):25-30. PubMed ID: 1711395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
    Nishikawa T; Mataga N; Takashima M; Toru M
    Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
    Muraki A
    Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
    Lan KC; Ma T; Lin-Shiau SY; Liu SH; Ho IK
    J Biomed Sci; 2008 May; 15(3):391-403. PubMed ID: 17934798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
    Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
    Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-dependent effects of chronic stress on apomorphine-induced alterations of striatal and mesolimbic dopamine metabolism.
    Cabib S; Puglisi-Allegra S
    Brain Res; 1991 Feb; 542(1):91-6. PubMed ID: 2054663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.
    Zetterström T; Ungerstedt U
    Eur J Pharmacol; 1984 Jan; 97(1-2):29-36. PubMed ID: 6199219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of the brain dopamine system in mice carrying the quaking neurological mutation].
    Nikulina IuA; Skrinskaia IuA; Popova NK
    Biull Eksp Biol Med; 1988 Aug; 106(8):212-4. PubMed ID: 3262000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic regulation of striatal dopaminergic grafts during locomotor activity.
    Hattori S; Hashitani T; Matsui N; Nishino H
    Brain Res; 1996 Feb; 710(1-2):45-55. PubMed ID: 8963678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of a subchronic post-lesion treatment with (-)-deprenyl on the sensitivity of 6-OHDA-lesioned rats to apomorphine and d-amphetamine.
    Spooren WP; Waldmeier P; Gentsch C
    J Neural Transm (Vienna); 1999; 106(9-10):825-33. PubMed ID: 10599865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.